Showing results (111-120 of 276) with videos related to
Sort By:
Pageof 28
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 31, 2023
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study GroupPauline Wimberger, Jacobus Pfisterer, Andreas du Bois, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 5, 2013
Synchronous ovarian and endometrial cancer--an international multicenter case-control studyFlorian Heitz, Frederic Amant, Christina Fotopoulou, et al.Gynecologic Oncology|May 24, 2024
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational statusClaudia Marchetti, Beyhan Ataseven, Anna M Perrone, et al.Annals of Surgical Oncology|September 6, 2017
Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian CancerAnnett Kahl, Andreas du Bois, Philipp Harter, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)Philipp Harter, David Gershenson, Catherine Lhomme, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2019
Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trialBeyhan Ataseven, Johanna Frindte, Philipp Harter, et al.Cancer Research|July 3, 2008
NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomasKnut Engels, Shirley K Knauer, Sibylle Loibl, et al.Gynecologic Oncology|October 5, 2014
Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trialChee Khoon Lee, Sarah Lord, Tami Grunewald, et al.Gynecologic Oncology|March 16, 2016
Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgeryFlorian Heitz, Philipp Harter, Piero F Alesina, et al.Cancer|April 11, 2016
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapyUrsula A Matulonis, Philipp Harter, Charlie Gourley, et al.Pageof 28